Comparative study of lactoferrin and iron supplement for treatment of iron deficiency anemia in children with inflammatory bowel disease

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202002763901803

Enrollment

Registered

2020-02-24

Start date

2020-02-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Paediatrics

Interventions

iron supplement group

lactoferrin group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children of inflammatory bowel disease with iron deficiency anemia (Hb level less than 11 g\dl) will be included in our study

Exclusion criteria

Exclusion criteria: patients with infection, other chronic diseases, personal or family history of allergy to cow's milk or recent iron supplement administration or blood transfusion within the previous 3 months will be excluded in our study

Design outcomes

Primary

Measure	Time frame
compare the effect of lactoferrin versus iron supplement in treatment of iron deficiency anemia in children with inflammatory bowel disease	—

Secondary

Measure	Time frame
side effects of both drugs	—

Countries

Egypt

Contacts

Public ContactMohamed Elkashlan

consultant of anesthesiology

mohamedkashlan@yahoo.com00201222337746

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026